Loading
AP
Alexza Pharmaceuticals Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Grupo Ferrer Internacional, S.A., was filed 22 Jun 2016.
Alexza Pharmaceuticals Inc.: what insiders have been doing
Alexza Pharmaceuticals Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). Alexza Pharmaceuticals Inc. has had no insider filing for more than a year; the last one goes back to 22 June 2016.
The full history, which starts in 2016, counts 2 purchases against no sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
13
Thresholds
n/a
Buy Volume
€16M
2 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 22 June 2016
Declarations13 total
19,465,714 shares@ US$0.90100.0% of flowCommon StockSEC:0001209191-16-129191:0
Canonical exit: 19 Sept 2016 (T+90)
15,838 sharesCommon StockSEC:0001209191-16-129007:0
32,392 sharesCommon StockSEC:0001209191-16-129004:0
927 sharesCommon StockSEC:0001209191-16-129004:1
927 sharesCommon StockSEC:0001209191-16-129004:2
3,492 sharesCommon StockSEC:0001209191-16-129000:0
1,050 sharesCommon StockSEC:0001209191-16-129011:0
9,112 sharesCommon StockSEC:0001209191-16-129018:0
658 sharesCommon StockSEC:0001209191-16-128996:0
98,967 sharesCommon StockSEC:0001209191-16-128996:1
37,224 sharesCommon StockSEC:0001209191-16-129014:0
40,000 sharesCommon StockSEC:0001209191-16-129014:1
125,000 sharesCommon StockSEC:0001209191-16-104976:0
Canonical exit: 27 Dec 2015 (T+90)
13 of 13 declarations
About Alexza Pharmaceuticals Inc.
Alexza Pharmaceuticals Inc. is a biopharmaceutical company focused on developing treatments for neurological and psychiatric disorders. The company is listed on NASDAQ under the symbol ALXA.
